New oral anticoagulants for AF
Links shared publicly online about this topic.
- 191total visits
New oral anticoagulants for AF
View full resource at drjohnm.org
Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, Anti-Clotting Medication, Anticoagulant, News
Most Recently Shared on June 26, 2011 at 1:36 pm By:
Some thoughts on recent AF (#afib) news... Part 1- New blood thinners http://ow.ly/5qx3r
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 28, 2012 at 2:51 am By:
Dr Ted Portnay Doctor, Internist, Cardiologist, and Physician
New oral anticoagulants in #AF: What to do in clinical practice http://t.co/dxgStren
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 27, 2012 at 7:56 pm By:
New oral anticoagulants in AF: What to do in clinical practice http://t.co/dRIaE4ER #ACC12
#132: "Real-world" analysis: New anticoagulants better than warfarin in AF; PTCA pioneer passes away: Dr Geoffrey Hartzler; Florida stem-cell cardiologist has license suspended; Dabigatran cost-effective vs warfarin; theheart.org's statin safety survey
radio.theheart.org — “"Real-world” View full resource at radio.theheart.org
Most Recently Shared on March 16, 2012 at 6:58 pm By:
#132: "Real-world" analysis: New anticoagulants better than warfarin in AF; PTCA pioneer passes away: Dr... http://t.co/DqmWqbq7
Dabigatran, rivaroxaban, apixaban vs warfarin: The parallax of the novel blood thinners
blogs.theheart.org — “Dabigatran, rivaroxaban, apixaban vs warfarin: The parallax of the novel blood thinners” View full resource at blogs.theheart.org
Most Recently Shared on March 13, 2012 at 10:14 am By:
Richard Vaughn MD Health Executive, Health IT, Physician, and Doctor
HT @medskep Dabigitran: 3 major issues: prescriber errors, dubious patient selection, & lack of reversal agents. http://t.co/igiO5CMI
American College of Surgeons Surgery News UPDATE: New Anticoagulants Promising but Problematic
facs.org — “Because anticoagulation is a balancing act between the prevention of clots and the risk of major bleeds, tremendous efforts have been made to find the safest, most effective drugs possible. The foundations of anticoagulant therapy – warfarin (taken orally) and heparin (taken intravenously) – are being shaken by an onslaught of the newer oral factor Xa inhibitors.” View full resource at facs.org
Most Recently Shared on March 10, 2012 at 5:26 pm By:
Chris Porter Doctor, Surgeon, and Physician
New Anticoagulants Promising but Problematic http://t.co/CyCzDzBA
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 7, 2012 at 7:44 pm By:
New anticoagulants better than warfarin in AF, says new "real-world" analysis http://t.co/cljRQ64c
Decision on Apixaban (Eliquis) Pushed Back By Three Months - Forbes
forbes.com — “Confirming earlier speculation by a Wall Street analyst, Pfizer and Bristol-Myers Squibb announced on Wednesday evening that the FDA had extended by three months the action date for the new drug application (NDA) for the highly anticipated oral anticoagulant Eliquis (apixaban). The application is for their important indication of stroke [...]” View full resource at forbes.com
Most Recently Shared on March 1, 2012 at 11:54 am By:
Maybe a Pradaxa side effect, analyst says RT @blogaceutics: #FDA Decision on Eliquis Pushed Back By Three Months—Forbes http://t.co/pesyJ6FF
New Oral Anticoagulants Troublesome in Trauma Setting : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on January 26, 2012 at 4:43 pm By:
Miriam E. Tucker Patient Expert
RT @IntMedNews: New Oral Anticoagulants Troublesome in Trauma Setting http://t.co/r3PUhkii
Bad Request
stopafib.org — “Bad Request” View full resource at stopafib.org
Most Recently Shared on January 25, 2012 at 1:19 pm By:
Update: New Atrial Fibrillation Stroke Prevention Meds: Video interview w/ Dr. Singer: http://t.co/lQ6s27hN #afib #AF
Medical News: Readers: Cancer Screening, Lipitor, and Politics Top 2011 News - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “In response to MedPage Today's end-of-the-year survey, readers chose as top stories the changes in prostate and mammography screening, generic Lipitor, and the new class of oral anticoagulant” View full resource at medpagetoday.com
Most Recently Shared on January 7, 2012 at 6:12 pm By:
Readers: Cancer Screening, Lipitor, and Politics Top 2011 News http://t.co/lcRkVBcG
Eliquis: new oral anticoagulant | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on November 2, 2011 at 9:58 am By:
New oral anticoagulant, Eliquis (apixaban), launched: http://t.co/Xpw0D7BL
One in three AF patients at high risk of stroke are not being prescribed VKA therapy
news-medical.net — “New data show that, worldwide, one in three patients with atrial fibrillation (AF) who are at high risk for stroke are not being prescribed anticoagulant therapy, particularly vitamin K antagonists (VKA) – medicines known to significantly lower stroke risk in these patients.” View full resource at news-medical.net
Most Recently Shared on August 29, 2011 at 9:30 am By:
One in three AF patients at high risk of stroke are not being prescribed VKA therapy: New data show that, worldw... http://t.co/ftCw7yh
NICE wants more information on Pradaxa | InPharm
inpharm.com — “NICE wants more information on Boehringer Ingelheim’s Pradaxa, after deciding the blood thinning drug is not currently cost-effective” View full resource at inpharm.com
Most Recently Shared on August 17, 2011 at 8:41 am By:
Pharmafocus Health News and Pharma
NICE wants more information on Pradaxa http://ow.ly/65bK5 #pharma #nhs
Recently UK Licensed Anticoagulant "Pradaxa" Could Benefit Thousands Of Eligible Atrial Fibrillation Patients
medicalnewstoday.com — “The first new oral anticoagulant for the prevention of stroke and systemic embolism will be available in the UK from the 18th August 2011, after the EU license is granted on the 1st August this ye” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2011 at 3:05 pm By:
MNT Drug Approvals Health News
Recently UK Licensed Anticoagulant "Pradaxa" Could Benefit Thousands Of Eligible Atrial Fibrillation Patients http://mnt.to/3YYB #regulatory
Royal Pharmaceutical Society | RPS endorses guidance on Anticoagulants
rpharms.com — “RPS endorses guidance on Anticoagulants” View full resource at rpharms.com
Most Recently Shared on August 10, 2011 at 8:44 am By:
RPS endorses UKCPA position statement on new oral anticoagulants for stroke prevention in atrial fibrillation: http://t.co/F1k6It2
Advertisement
